These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15155209)

  • 1. Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum.
    Gatton ML; Martin LB; Cheng Q
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2116-23. PubMed ID: 15155209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
    Djaman JA; Mazabraud A; Basco L
    Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.
    Mita T; Ohashi J; Venkatesan M; Marma AS; Nakamura M; Plowe CV; Tanabe K
    J Infect Dis; 2014 Jan; 209(1):130-9. PubMed ID: 23922363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfadoxine-pyrimethamine resistance in Plasmodium falciparum: a zoomed image at the molecular level within a geographic context.
    Abdul-Ghani R; Farag HF; Allam AF
    Acta Trop; 2013 Feb; 125(2):163-90. PubMed ID: 23131424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of an unusual sulfadoxine-pyrimethamine resistance pattern and a novel K540N mutation in dihydropteroate synthetase in Plasmodium falciparum isolates obtained from Car Nicobar Island, India, after the 2004 Tsunami.
    Lumb V; Das MK; Mittra P; Ahmed A; Kumar M; Kaur P; Dash AP; Singh SS; Sharma YD
    J Infect Dis; 2009 Apr; 199(7):1064-73. PubMed ID: 19220141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles.
    Chauvin P; Menard S; Iriart X; Nsango SE; Tchioffo MT; Abate L; Awono-Ambéné PH; Morlais I; Berry A
    J Antimicrob Chemother; 2015 Sep; 70(9):2566-71. PubMed ID: 26080363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI; Little F; Mabuza A; Mngomezulu N; Govere J; Durrheim D; Roper C; Watkins B; White NJ
    J Infect Dis; 2008 Jun; 197(11):1605-13. PubMed ID: 18471066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F; Herrera S; Murrain B; Gutiérrez A; Moreno LA; Manzano M; Muñoz A; Plowe CV
    Am J Trop Med Hyg; 2007 Sep; 77(3):438-43. PubMed ID: 17827356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
    Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
    Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of sulfadoxine/pyrimethamine resistance alleles in Plasmodium falciparum parasites from Bangladesh.
    Marma AS; Mita T; Eto H; Tsukahara T; Sarker S; Endo H
    Parasitol Int; 2010 Jun; 59(2):178-82. PubMed ID: 20097306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania.
    Baraka V; Ishengoma DS; Fransis F; Minja DT; Madebe RA; Ngatunga D; Van Geertruyden JP
    Malar J; 2015 Nov; 14():439. PubMed ID: 26542942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H; Imada Y; Vannachone B; Miyagi M; Kobayashi J; Uechi G; Pethuvang R; Manivong K; Phompida S; Sato Y
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
    Alifrangis M; Lemnge MM; Rønn AM; Segeja MD; Magesa SM; Khalil IF; Bygbjerg IC
    Am J Trop Med Hyg; 2003 Sep; 69(3):238-43. PubMed ID: 14628937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
    Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S; Kheir A; Abdel-Muhsin AM; Al-Ghazali A; Nwakanma D; Swedberg G; Babiker HA
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M; Enosse S; Khalil IF; Tarimo DS; Lemnge MM; Thompson R; Bygbjerg IC; Rønn AM
    Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.